Skip to main content

Table 1 Overlap between selected top features from CCLE and CGP. For each drug, the table shows the number of common genes between CCLE_Impor and CGP_Impor and overlapping significance by Fisher’s exact test

From: Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection

Drug 1-500 p-value 501-1000 p-value 1001-1500 p-value
AZD6244 79 3.716 49 3.277 30 3.48
e-25   e-8   e-2
Erlotinib 79 3.716 47 2.225 38 3.47
e-25   e-7   e-4
PHA665752 72 1.603 40 8.163 33 7.76
e-20   e-5   e-3
AZD0530 72 1.603 42 1.722 32 1.32
e-20   e-5   e-2
Paclitaxel 74 8.309 45 1.368 39 1.71
e-22   e-6   e-4
PF-2341066 80 7.541 41 3.801 28 8.06
e-26   e-5   e-2
Sorafenib 79 3.716 31 2.177 22 0.46
e-25   e-2   
PD-0325901 78 1.80 54 1.803 28 8.06
e-24   e-10   e-2
Lapatinib 68 4.78 46 5.586 33 7.76
e-18   e-7   e-3
PLX4720 78 1.80 41 3.801 29 5.38
e-24   e-5   e-2
PD-0332991 68 4.78 39 1.706 28 8.06
e-18   e-4   e-2